FDA Approves Quarterable Previcox Tablets for Dogs

FDA approval has been reported for quarterable Previcox tablets for dogs. According to Today’s Veterinary Business, the product is from Boehringer Ingelheim and is a double-scored, quarterable NSAID.

The announcement centers on the tablet’s physical design: the double-scored format enables the tablet to be divided into quarters. Today’s Veterinary Business reports that this configuration is intended to support customized dosing and reduce medication waste.

Tablet design and customized dosing

Today’s Veterinary Business identifies the newly approved Previcox tablets as double-scored and quarterable. The reported design gives veterinary teams a tablet format that can be divided into quarters for dogs receiving the NSAID.

Customized dosing is a stated purpose of the formulation. For veterinary sales professionals, the approval provides a product-specific update to discuss with practices, focused on the FDA-approved tablet configuration and its role in dosing conversations.

Discussions can remain grounded in the reported product features: Boehringer Ingelheim’s Previcox tablets are quarterable, double-scored and intended to enable customized dosing. Practice teams evaluating the formulation can review the applicable product information for dogs.

Medication-waste consideration

In addition to customized dosing, Today’s Veterinary Business reports that the quarterable tablet design is intended to reduce medication waste. The report connects the double-scored configuration with a practical medication-management consideration for canine patients.

The approval gives veterinary professionals a defined product development to note: an FDA-approved, quarterable Previcox tablet for dogs. The manufacturer is Boehringer Ingelheim, and the product is described by Today’s Veterinary Business as an NSAID.

Key points from the report

• The FDA approved quarterable Previcox tablets for dogs.
• Boehringer Ingelheim makes the product.
• The tablets are described as double-scored and quarterable.
• The design enables customized dosing, according to Today’s Veterinary Business.
• The tablet format is intended to reduce medication waste.

For veterinary sales teams, the event is a focused FDA approval update. Conversations with veterinary practices can address the reported tablet design, the customized-dosing purpose and the medication-waste objective without extending beyond the information published by Today’s Veterinary Business.